Screener
Halozyme Therapeutics HALO Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
FAQ
- What is Halozyme Therapeutics's total assets?
- Halozyme Therapeutics (HALO) reported total assets of $2.58B in Q2 2026.
- How has Halozyme Therapeutics's total assets changed year-over-year?
- Halozyme Therapeutics's total assets increased by 25.5% year-over-year, from $2.05B to $2.58B.
- What is the long-term trend for Halozyme Therapeutics's total assets?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's total assets has grown at a 34.2% compound annual growth rate (CAGR), from $579.92M to $2.53B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Halozyme Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude